Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,177 | -53,635 | -33,018 | N/A | N/A |
| Depreciation Amortization | 674 | 404 | 221 | N/A | N/A |
| Accounts receivable | -3,954 | -104 | -158 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,266 | -386 | 3,378 | N/A | N/A |
| Other Working Capital | 28,434 | 41,415 | 11,641 | N/A | N/A |
| Other Operating Activity | 32,830 | 27,729 | -315 | 0 | 0 |
| Operating Cash Flow | $-23,927 | $15,423 | $-18,251 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,849 | -373 | -1,783 | N/A | N/A |
| Net Acquisitions | 2,334 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -10 | 0 | -40 | 0 | 0 |
| Investing Cash Flow | $-525 | $-373 | $-1,823 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 9,950 | N/A | N/A | N/A |
| Common Stock Issued | 85,474 | 6 | N/A | N/A | N/A |
| Common Stock Repurchased | -2 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 50,484 | 0 | 26,938 | 0 | 0 |
| Financing Cash Flow | $135,956 | $9,956 | $26,938 | $N/A | $N/A |
| Exchange Rate Effect | -666 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 39,554 | 14,548 | 7,684 | N/A | N/A |
| End Cash Position | 150,392 | 39,554 | 14,548 | N/A | N/A |
| Net Cash Flow | $110,838 | $25,006 | $6,864 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,927 | 15,423 | -18,251 | N/A | N/A |
| Capital Expenditure | -2,849 | -373 | -1,783 | N/A | N/A |
| Free Cash Flow | -26,776 | 15,050 | -20,034 | 0 | 0 |